Pharmacy Podcast Network

In this episode, Jeremy and Jessica talk with Paul Sabatini, M.Ed, CPhT, FCSHP.  Paul has worked in the pharmacy profession for 30 years.  Most recently, he was recognized by the California Pharmacists Association (CPhA) and NHA as the recipient of the 2020 Pharmacy Technician of the Year Award. His dynamic and unique career path has not only involved working in multiple pharmacy settings, but has also been a force in higher education in the state of California.  As an instructor, and program director of pharmacy technician educational programs, Paul has helped countless individuals to prepare for and launch successful careers in pharmacy. Recently, his mission to improve the workforce has been demonstrated through his relentless work to advocate for and organize pharmacy technicians to advance their skills and scope of practice in the state of California.  You won’t want to miss this episode, especially if you’re a technician practicing in California!  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The recently published STEP trial showed a dramatic effect on weight loss with the weekly injectable semaglutide versus placebo. Lay media picked up the headlines from this potential "GameChanger" medication for weight loss. With this one shot will patient lose themselves? Reference: Wilding J, Batterham R, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. February 10, 2021. DOI: 10.1056/NEJMoa2032183 CPE details for GameChangers Podcast March 2021 Learning Objective: Discuss the design of the STEP trial 0107-0000-21-097-H01-P 0.25 CEU/2.5 Hrs (Knowledge) Initial Release Date: 03/02/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Like many health systems, Allegheny Health Network was challenged by the cost, compliance, and complexity of compounding sterile products (CSPs). Learn how Allegheny Health Network innovated its CSP program using advanced robotics and expert technicians, leading to enhanced safety, improved practices, and cost savings. Guest: Arpit Mehta, PharmD, MPH, MHA, Director of Pharmacy, Allegheny General Hospital Host: Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of Beyond the Sig, third-year student pharmacist Brooke Kulusich chats with Kevin Day, PharmD, President of Day’s Miami Heights Pharmacy in Cincinnati, Ohio and Managing Network Facilitator of CPESN Ohio. Kevin shares his insight into the network’s efforts to provide enhanced patient care services and the implications of provider status for pharmacists in Ohio. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

DIR (Direct & Indirect Remuneration) fees aren't just a pharmacy problem. They affect almost every area of the healthcare spectrum. Tune in as PUTTcast hosts Lauren Young and Monique Whitney welcome special guests; oncologist Dr. Michael Diaz, legal counsel Mark Cuker, and IL independent pharmacist & pharmacy owner Byron Berry to discuss the widespread effects and legalities of DIR fees - and what can (and should!) be done about them going forward. Hosts: Lauren Young, PUTT Board Member & IL independent pharmacy owner Monique Whitney, PUTT Executive Director Special Guests:  Dr. Michael Diaz, Immediate Past President, Community Oncology Alliance, Assistant Managing Partner, Florida Cancer Specialists Byron Berry, RPh, President, Pharmacy Plus Pharmacies Mark Cuker, Esq, Counsel, Jacobs Law Group See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In the summer of 2016, Jason Dykstra, PharmD. took the leap of faith and left his long-time position with a major grocery store pharmacy chain and opened his own independent pharmacy.  In this episode Dykstra talks about how he made this decision and shares several tips on what he has done to become successful so quickly. In this 30-minute podcast Dykstra talks about how he and his wife worked together to create a pharmacy that was both functional and appealing.  The décor, layout and front-end product selection were all done with an eye towards making the pharmacy appealing and to provide items not easily sold by his chain competition.  This even included a special children’s play area.     Dykstra discusses the importance of carefully monitoring inventory.  He also talks about how he often works with prescribers to help patients get a comparable medication at a lower co-pay; while, also often improving his margin.  Dykstra points out that pharmacy is both a business and a profession and emphasizes that, as an owner, “If you can’t keep the doors open then the people you care for won’t benefit from the care you provide.” Included are comments on a specific vendor he uses to search for better prices from a variety of suppliers.  He also talks about how important it is to know who your “key” customers are and coaching the staff on how to make sure these people are well taken care of as they not only purchase more, and more profitable items but they are the people who tell others about how great your pharmacy is.  Jason’s success with his first independent pharmacy has gone so well that in Dec. 2020 he opened a second location about 20 miles away in another rural community and has already started the process of getting permits to refurbish a building in a third town with hopes of opening a pharmacy there late in 2021.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

What's the expected outcomes of a transparent PBM? How does a fiduciary driven pharmacy benefit management company compare to the 3 largest PBMs in the country processing more than 76% of all the prescriptions per year in the United States.  The PBM market is dominated by three major players, who together handled about 76 percent of all prescription claims in 2018, according to Drug Channels Institute.   A breakdown of PBM market share, by total equivalent prescription claims managed in 2018:   Caremark (CVS Health) / Aetna: 30 percent Express Scripts: 23 percent   OptumRx (UnitedHealth): 23 percent   Humana Pharmacy Solutions: 7 percent   MedImpact Healthcare Systems: 6 percent   Prime Therapeutics: 6 percent   All other PBMs + cash pay: 4 percent  TrueScriptsmission is to build lasting relationships. They provide prescription benefit management expertise at a personal and customized level to ensure optimum value at the lowest possible cost. The TrueScripts team of nurses, pharmacists, legal experts, data scientists, and care specialists work together as one to bring prescription benefit expertise and a level of service that far exceeds that of any industry standard.  Today's guest is Nathan Gabhart RPh Founder & CEO of TrueScripts.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Chris Abkarians Co-Founder at Juno discusses strategies to minimize your student loan debt. Take advantage of this program: JoinJuno.loan Intro clip from CBS 8 San Diego  On YouTube: Pressure mounting for President Biden to wipe out student loan debt About Juno:  Juno’s founders, Nikhil Agarwal and Chris Abkarians were admitted to Harvard and then the dreaded tuition bill came. That summer, instead of taking expensive loans, they got 700 students from 10 schools together and negotiated lower rates for the entire group, saving their classmates ~$15K each. Juno came into existence from their desire to make this benefit available to all future generations of students. Today, Juno is able to get the lowest rate student loans for thousands.  Learn more: JoinJuno.loan  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The endocannabinoid system is influenced by compounds found the Cannabis genus of plants and involves two compounds: cannabidiol (CBD) and tetrahydrocannabinol (THC). Federal and state regulation is changing, so the medicinal and recreatoinal use of cannabis-related prodcuts continues to increase. Although not life-threatening, some patients may experience Cannabis Hyperemesis Syndrome. Fortunately, a narrative review outlines the causes and treatment to help get out the weeds of treatment. Reference: Perisetti A, Gajendran M, Dasari C, et al. Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Annals of Gastroenterology (2020) 33, 1-8. http://www.annalsgastro.gr/files/journals/1/earlyview/2020/ev-09-2020-01-AG_5230-0528.pdf  CPE details for GameChangers Podcast March 2021 Learning Objective: Describe the potential mechanisms and treatment options for Cannabis Hyperemesis Syndrome. 0107-0000-21-097-H01-P 0.25 CEU/2.5 Hrs (Knowledge) Initial Release Date: 03/02/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Becky Winslow PharmD, of PGX for Pharmacists podcast, joins Eric Geyer PharmD in this mash-up 'Pharmacy Podcast' hybrid episode where we discuss not only the Plavix case but several other cases where pharmacogenomics could help make a huge difference in our healthcare system, including in how we treat opioid addiction. Hawaii recently fined Bristol Myers Squibb and Sanofi under consumer protection standards for their drug Plavix (clopidogrel). This could be a game changing case due to the fact that it could have been prevented with more studies using pharmacogenomics.  Special insert from KHON2 News with Hawaii Attorney General Clare Connors held a news conference on Tuesday to discuss the million-dollar lawsuit against Bristol-Myers Squibb Co. and Sanofi. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices